NeoGenomics, Inc. (NEO) Total liabilities 2016–2025
NeoGenomics, Inc. (NEO) total liabilities at each fiscal year-end, per SEC filings.
$523.3MFY2025 · since FY2016: $150.5M → $523.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $523.3M | -28.9% |
| FY2024 | $735.7M | -0.5% |
| FY2023 | $739.7M | -0.3% |
| FY2022 | $742.0M | -2.6% |
| FY2021 | $761.5M | +159.0% |
| FY2020 | $294.0M | +45.5% |
| FY2019 | $202.1M | +9.5% |
| FY2018 | $184.6M | +32.0% |
| FY2017 | $139.9M | -7.1% |
| FY2016 | $150.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice